Real World Evidence
From epidemiology, treatment patterns, and HCRU/cost studies to treatment adherence/persistence, patient preference, and post-approval safety studies, Cytel RWE experts provide data-driven insights that get your product into the hands of the patients who need them most. Our unrivalled knowledge of advanced analytics, robust methods and strategic innovation in research sets us apart. With expertise harnessing the power of data across a diverse array of international geographies, we balance scientific rigor with commercial awareness to provide you with the evidence you need to launch new products, overcome regulatory hurdles and achieve payer approval.
Why Cytel RWE?
The Cytel RWE team takes pride in providing tailored, flexible, fit-for-purpose solutions which are focused on our client’s needs. We are one of the largest RWE groups in the industry, but with the flexibility and commitment you would expect from a much smaller company.
Our network of databases include unique and exclusive access to data globally which is ideal for enabling multi-country studies. We have unique capabilities and analytical frameworks to plan and conduct database studies and other types of RWE studies such as medical chart reviews and/or surveys. All our RWE studies are based on a portfolio of analytical methods such as synthetic control group comparisons, advanced matching techniques, time to event endpoints and difference in difference analyses, time-dependent independent variables, and latent class analyses in DCE studies.